NCT05558423

Brief Summary

The timing of food intake (chrononutrition) is emerging as a key regulator of circadian rhythm in metabolic organs. A wealth of research has been conducted on intermittent fasting, and time restricted eating (TRE) specifically, investigating the temporal patterns of diet (eating window, time of eating, time of largest energy intake) and their impact on disease risk, with overall beneficial impact on health. Studies have been conducted in a parallel or single arm design, while cross-over and the efficacy of TRE in ameliorating appetite and symptom burden within an individual remains unclear.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
26 days until next milestone

Study Start

First participant enrolled

October 24, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2023

Completed
Last Updated

November 30, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 23, 2022

Last Update Submit

November 25, 2022

Conditions

Keywords

Intermittent FastingTime Restricted EatingHungerMoodEnergy

Outcome Measures

Primary Outcomes (6)

  • TRE window clock time

    The chosen clock time for the TRE window (early, vs. middle, vs. late)

    2 weeks

  • Habitual eating window clock time

    The chosen clock time for the habitual eating window

    1 weeks

  • Hunger

    Hunger levels reported by visual analogue scale ("how hungry did you feel yesterday?"; 0-10; where 10 is the most hungry)

    3 weeks (plus optional unlimited weeks)

  • Mood

    Mood levels reported by visual analogue scale ("how was your mood yesterday?"; 0-10; where 10 is most positive)

    3 weeks (plus optional unlimited weeks)

  • Energy

    Energy levels reported by visual analogue scale ("how energetic did you feel yesterday?"; 0-10; where 10 is most energetic)

    3 weeks (plus optional unlimited weeks)

  • Symptom burden

    The self-reported symptom burden while completing both habitual and TRE phases

    3 weeks (plus optional unlimited weeks)

Secondary Outcomes (3)

  • Body weight

    3 weeks (plus optional unlimited weeks)

  • Gastrointestinal symptoms

    3 weeks (plus optional unlimited weeks)

  • Eating habits

    3 weeks (plus optional unlimited weeks)

Study Arms (1)

Self-controlled

EXPERIMENTAL

n-of-1 design. Participants complete a baseline habitual eating phase following by an intervention TRE phase.

Behavioral: Time Restricted Eating

Interventions

Participants are asked to follow a Time Restricted Eating regimen with eating window of ≤10 hours.

Self-controlled

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults of 18 years and above, where the app has been approved for download from the Apple App and Google Play stores.

You may not qualify if:

  • Unable to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ZOE Limited

London, SE1 7RW, United Kingdom

RECRUITING

MeSH Terms

Conditions

Intermittent Fasting

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Study Officials

  • Tim Spector, Pr

    Zoe Ltd, King's College London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2022

First Posted

September 28, 2022

Study Start

October 24, 2022

Primary Completion

October 24, 2023

Study Completion

October 24, 2023

Last Updated

November 30, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations